Clinical Trial Update: Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of Flavopiridol (alvocidib) and imatinib mesylate in patients with leukemia has completed, reporting early clinical eva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Alvocidib (Flavopiridol)
• Gleevec (Imatinib)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Leukemia | Phase 1 | Status: COMPLETED